logo
AAT Bioquest

Transfectamine™ mRNA Transfection Reagent

Transfectamine™ mRNA Transfection Reagent is a powerful and versatile transfection reagent designed to introduce a higher amount of mRNA into eukaryotic cells, or more specifically, into animal cells. It delivers high transfection efficiency in a wide variety of adherent and suspension cell lines, including difficult-to-transfect cells. Nuclear uptake is not required, which results in faster protein expression than DNA transfection without the risk of genomic integration. The low toxicity of Transfectamine™ mRNA Transfection Reagent allows higher viability of transfected cells. Transfectamine™ mRNA Transfection Reagent does not require special medium and is easier to use compared to most of the commercial transfection reagents.
Transfection efficiency comparison (Upper panel) and cellular toxicity comparison (Bottom panel) in HeLa cells. HeLa cells were cultured in a 6-well plate to ~90% confluency. 2.5 µg of mRNA was transfected with Lipofectamine MessengerMAX and Transfectamine™ mRNA Transfection Reagent, respectively. Images were taken 18 hours after the transfection using a fluorescent microscope with the FITC channel (Upper panel). Although transfection efficiency was similar for Lipofectamine MessengerMAX and Transfectamine™ mRNA Transfection Reagent, most Lipofectamine MessengerMAX transfected samples were scrambled, whereas cells transfected with Transfectamine™ mRNA Transfection Reagent looked much healthier (bottom panel).
Transfection efficiency comparison (Upper panel) and cellular toxicity comparison (Bottom panel) in HeLa cells. HeLa cells were cultured in a 6-well plate to ~90% confluency. 2.5 µg of mRNA was transfected with Lipofectamine MessengerMAX and Transfectamine™ mRNA Transfection Reagent, respectively. Images were taken 18 hours after the transfection using a fluorescent microscope with the FITC channel (Upper panel). Although transfection efficiency was similar for Lipofectamine MessengerMAX and Transfectamine™ mRNA Transfection Reagent, most Lipofectamine MessengerMAX transfected samples were scrambled, whereas cells transfected with Transfectamine™ mRNA Transfection Reagent looked much healthier (bottom panel).
Transfection efficiency comparison (Upper panel) and cellular toxicity comparison (Bottom panel) in HeLa cells. HeLa cells were cultured in a 6-well plate to ~90% confluency. 2.5 µg of mRNA was transfected with Lipofectamine MessengerMAX and Transfectamine™ mRNA Transfection Reagent, respectively. Images were taken 18 hours after the transfection using a fluorescent microscope with the FITC channel (Upper panel). Although transfection efficiency was similar for Lipofectamine MessengerMAX and Transfectamine™ mRNA Transfection Reagent, most Lipofectamine MessengerMAX transfected samples were scrambled, whereas cells transfected with Transfectamine™ mRNA Transfection Reagent looked much healthier (bottom panel).
Cell viability comparison in HeLa cells. HeLa cells were incubated with Transfectamine™ mRNA Transfection Reagent and Lipofectamine MessagerMax, respectively, according to suggested protocol without mRNA. After 24 hours, cell viability in both groups was measured with Cell Meter™ Colorimetric WST-8 Cell Quantification Kit (Cat#22770). The higher absorbance at 460 represents more numbers of viable cells.
Ordering information
Price
Unit size
50 uL
0.5 mL
5 mL
Catalog Number
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
SolventWater
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
UNSPSC12171501
Example protocol

AT A GLANCE

Protocol Summary
  1. Prepare cells for transfection.

  2. Prepare the Transfectamine™ mRNA Transfection Reagent-RNA mixture.

  3. Add the Transfectamine™ mRNA Transfection Reagent-RNA mixture to the cell culture.

  4. Culture cells overnight.

  5. Analyze transfection efficiency with an appropriate method.

CELL PREPARATION

  1. Culture cells to ~ 90% confluency at the time of transfection.

  2. Replace with fresh growth medium before transfection. For example, replace with 2 mL of medium per well for 6-well plates and 6 mL of medium for 10 cm plates.

PREPARATION OF WORKING SOLUTION

Transfectamine™ mRNA Transfection Reagent-RNA mixture
  1. Mix 2.5 µg of mRNA with 200 µL of serum-free medium.

  2. Add 7.5 µL of Transfectamine™ mRNA Transfection Reagent to Step 1.

  3. Mix well and incubate at RT for 20 minutes.

    Note: The ratio of Transfectamine™ mRNA Transfection Reagent to mRNA needs to be optimized for different cell lines. In general, Transfectamine™ mRNA Transfection Reagent (µL) to mRNA (µg) Ratio = (3 to 5 µL) to 1 µg.

     

     

Table 1. Sample protocol detail for 6-well plates as shown in the table below.

Component6-well plate (per well)
Fresh culture medium2 mL
Purified mRNA~2.5 µg
Serum-free medium200 µL
Transfectamine™ mRNA Transfection Reagent~7.5 µL

SAMPLE EXPERIMENTAL PROTOCOL

Transfection Protocol
  1. Add the Transfectamine™ mRNA Transfection Reagent -mRNA mixture to the culture plate and culture overnight.

    Note: Recombinant protein expression can be detected as early as 8 hours after the transfection. Maximal expression level may be observed ~24 hours after the transfection.

References
View all 50 references: Citation Explorer
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma.
Authors: Lin, Liang and Cho, Shih-Feng and Xing, Lijie and Wen, Kenneth and Li, Yuyin and Yu, Tengteng and Hsieh, Phillip A and Chen, Hailin and Kurtoglu, Metin and Zhang, Yi and Andrew Stewart, C and Munshi, Nikhil and Anderson, Kenneth C and Tai, Yu-Tzu
Journal: Leukemia (2021): 752-763
YAF2-mediated YY1-Sirtuin6 interactions responsible formitochondrial down-regulation in aging tunicates.
Authors: Kawamura, Kaz and Higuchi, Takuma and Fujiwara, Shigeki
Journal: Molecular and cellular biology (2021)
LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro mRNA Transfection Compared to Liposomes.
Authors: Ayad, Camille and Libeau, Pierre and Lacroix-Gimon, Céline and Ladavière, Catherine and Verrier, Bernard
Journal: Pharmaceutics (2021)
PEGylation of poly(amine-co-ester) polyplexes for tunable gene delivery.
Authors: Grun, Molly K and Suberi, Alexandra and Shin, Kwangsoo and Lee, Teresa and Gomerdinger, Victoria and Moscato, Zoe M and Piotrowski-Daspit, Alexandra S and Saltzman, W Mark
Journal: Biomaterials (2021): 120780
Location of a single histidine within peptide carriers increases mRNA delivery.
Authors: He, Jiaxi and Xu, Songhui and Leng, Qixin and Mixson, A James
Journal: The journal of gene medicine (2021): e3295